Table 1 Association of NRP-1 expression with clinicopathologic parameters of nasopharyngeal carcinoma patients
From: Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma
Parameters | N | NRP-1 expression (n, %) | P | |
|---|---|---|---|---|
High | Low | |||
Age | ||||
< 48 | 100 | 63 (63.00) | 37 (37.00) | NS |
≥ 48 | 166 | 113 (68.07) | 53 (31.93) | |
Gender | ||||
Male | 166 | 106 (63.86) | 60 (36.14) | NS |
Female | 100 | 70 (70.00) | 30 (30.00) | |
Clinical stage | ||||
I ~ II | 68 | 30 (44.12) | 38 (55.88) | 0.02 |
III ~ IV | 198 | 146 (73.74) | 52 (27.26) | |
T-stage | ||||
T1 ~ T2 | 90 | 55 (61.11) | 35 (38.89) | NS |
T3 ~ T4 | 176 | 121 (68.75) | 55 (31.25) | |
N-stage | ||||
N0 | 78 | 50 (64.10) | 28 (35.90) | NS |
N1 ~ N3 | 188 | 126 (67.02) | 62 (32.98) | |
WHO histological type | ||||
II | 76 | 50 (65.79) | 26 (34.21) | NS |
III | 190 | 136 (71.58) | 54 (28.42) | |
Recurrence | ||||
No | 196 | 116 (59.18) | 80 (40.92) | 0.001 |
Yes | 70 | 60 (85.71) | 10 (14.29) | |
Metastasis | ||||
No | 211 | 128 (60.66) | 63 (39.34) | 0.001 |
Yes | 55 | 48 (87.27) | 7 (12.73) | |